Inventor · disambiguated record
Susan Ashwell
Also filed as: ASHWELL SUSAN · DRESSEN DARREN B · SARANTAKIS DIMITRIOS
51 granted patents·15 pending applications·715 citations·filing 1998–2024
99Inventor score
Top patents by PatentIndex Score
66 records- 0198US10550098B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·17 cites·25 claims
- 0298US10414752B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·19 cites·20 claims
- 0398US9834539B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Dec 5, 2017·28 cites·108 claims
- 0498US9624175B2Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·25 cites·39 claims
- 0598US9624216B2Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Apr 18, 2017·26 cites·74 claims
- 0697US11498913B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·4 cites·18 claims
- 0797US9771349B2Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Sep 26, 2017·27 cites·68 claims
- 0896US10005734B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Jun 26, 2018·25 cites·75 claims
- 0996US9815817B2Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Nov 14, 2017·24 cites·48 claims
- 1095US11497743B2Treating patients harboring an isocitrate dehydrogenase 1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2020·Granted Nov 15, 2022·3 cites·22 claims
- 1195US10889567B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Jan 12, 2021·5 cites·21 claims
- 1295US10280150B2Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2017·Granted May 7, 2019·19 cites·2 claims
- 1395US10266495B2Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2018·Granted Apr 23, 2019·19 cites·9 claims
- 1495US10253015B2Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2018·Granted Apr 9, 2019·20 cites·12 claims
- 1595US7378529B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted May 27, 2008·24 cites·23 claims
- 1695US6492372B1Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Dec 10, 2002·49 cites·6 claims
- 1795US6436904B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Aug 20, 2002·39 cites·32 claims
- 1894US10294206B2Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA TM2 INC·Filed 2015·Granted May 21, 2019·7 cites·16 claims
- 1994US6479492B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Nov 12, 2002·41 cites·7 claims
- 2093US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 2192US10577329B2Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Mar 3, 2020·4 cites·20 claims
- 2292US6911439B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2002·Granted Jun 28, 2005·28 cites·11 claims
- 2391US11963956B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·1 cites·20 claims
- 2491US10407419B2Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2015·Granted Sep 10, 2019·5 cites·5 claims
- 2588US11738018B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2021·Granted Aug 29, 2023·1 cites·20 claims
- 2688US10550099B2Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Feb 4, 2020·4 cites·15 claims
- 2788US6689781B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2001·Granted Feb 10, 2004·27 cites·9 claims
- 2887US12275715B2Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·23 claims
- 2987US10807976B2Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 20, 2020·2 cites·18 claims
- 3087US6900179B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 2001·Granted May 31, 2005·16 cites·13 claims
- 3186US7229970B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted Jun 12, 2007·2 cites·11 claims
- 3285US7973044B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jul 5, 2011·4 cites·19 claims
- 3384US11311527B2Inhibiting mutant isocitrate dehydrogenase 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2020·Granted Apr 26, 2022·1 cites·19 claims
- 3484US11013734B2Treating patients harboring an isocitrate dehydrogenase-1 (IDH-1) mutationFORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·24 claims
- 3584US6492421B1Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Dec 10, 2002·52 cites·35 claims
- 3683US7320960B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2002·Granted Jan 22, 2008·5 cites·20 claims
- 3783US6525026B2Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Feb 25, 2003·9 cites·18 claims
- 3883US2023125739A1Pyridin-2(1h)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3982US11576906B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Feb 14, 2023·1 cites·3 claims
- 4081US7968547B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2009·Granted Jun 28, 2011·2 cites·10 claims
- 4181US6489300B1Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4Filed 1998·Granted Dec 3, 2002·40 cites·22 claims
- 4280US6953802B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2001·Granted Oct 11, 2005·13 cites·28 claims
- 4380US2024148718A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4478US11013733B2Inhibiting mutant isocitrate dehydrogenase 1 (mlDH-1)FORMA THERAPEUTICS INC·Filed 2019·Granted May 25, 2021·1 cites·21 claims
- 4578US7291645B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2003·Granted Nov 6, 2007·7 cites·6 claims
- 4677US2025082628A1INHIBITING MUTANT ISOCITRATE DEHYDROGENASE 1 (mIDH-1)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4776US11376246B2Inhibiting mutant IDH-1FORMA THERAPEUTICS INC·Filed 2019·Granted Jul 5, 2022·1 cites·10 claims
- 4876US6291453B14-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Sep 18, 2001·20 cites·32 claims
- 4975US7223762B2Beta-amino acid derivatives-inhibitors of leukocyte adhesion mediated by VLA-4WYETH CORP·Filed 2005·Granted May 29, 2007·2 cites·17 claims
- 5075US7015216B2Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitorsWYETH CORP·Filed 2001·Granted Mar 21, 2006·8 cites·10 claims
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Susan Ashwell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →